Multi-antigen vectors of melanoma
US8911991B2 · kind B2 · utility
1Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 3, 2004 |
| Grant date | Dec 16, 2014 |
| Priority date | — |
| Expiry date | Dec 22, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/023
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to peptides, polypeptides, and nucleic acids and the use of the peptide, polypeptide or nucleic acid in preventing and/or treating cancer. In particular, the invention relates to peptides and nucleic acid sequences encoding such peptides for use in diagnosing, treating, or preventing melanoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.